MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Metastasis is the primary cause of breast cancer mortality.
• MicroRNAs (miRNAs) play a critical role in cancer progression, with aberrant expression linked to metastasis.
• miR-335 has been previously identified as a suppressor of tumor invasion and metastasis in breast cancer.

Purpose of the Study:

• To investigate the relationship between miR-335 expression and c-Met alteration in breast cancer.
• To elucidate the regulatory mechanism of miR-335 on c-Met.
• To determine the functional impact of the miR-335/c-Met axis on breast cancer cell migration.

Main Methods:

• Quantitative analysis of miR-335 and c-Met protein expression in human breast cancer cell lines.
• Luciferase reporter assays to validate direct targeting of c-Met 3' UTR by miR-335.
• Overexpression of miR-335 and assessment of c-Met levels and downstream signaling.
• Functional assays evaluating cell migration in response to hepatocyte growth factor (HGF) stimulation.
• Treatment with 5-aza-2'-deoxycytidine (5-AZA-CdR) to modulate miR-335 expression.

Main Results:

• miR-335 was downregulated, while c-Met protein was upregulated in tested breast cancer cell lines.
• miR-335 directly targets the 3' untranslated region (UTR) of c-Met, leading to decreased protein levels.
• Forced miR-335 expression inhibited HGF-induced c-Met phosphorylation and subsequent breast cancer cell migration.
• Upregulation of miR-335 by 5-AZA-CdR mimicked the inhibitory effects on cell migration.

Conclusions:

• miR-335 suppresses breast cancer cell migration and invasion.
• The suppressive effect is mediated through the negative regulation of the HGF/c-Met signaling pathway.
• Restoring miR-335 expression represents a potential therapeutic strategy for inhibiting breast cancer metastasis.